79 related articles for article (PubMed ID: 15081013)
1. Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries.
Liu L; Ping Li C; Cochran S; Ferro V
Bioorg Med Chem Lett; 2004 May; 14(9):2221-6. PubMed ID: 15081013
[TBL] [Abstract][Full Text] [Related]
2. A focused sulfated glycoconjugate Ugi library for probing heparan sulfate-binding angiogenic growth factors.
Liu L; Li C; Cochran S; Feder D; Guddat LW; Ferro V
Bioorg Med Chem Lett; 2012 Oct; 22(19):6190-4. PubMed ID: 22929233
[TBL] [Abstract][Full Text] [Related]
3. An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2.
Cochran S; Li CP; Bytheway I
Chembiochem; 2005 Oct; 6(10):1882-90. PubMed ID: 16175541
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a heparan sulfate mimetic library targeting FGF and VEGF via click chemistry on a monosaccharide template.
Liu L; Li C; Cochran S; Jimmink S; Ferro V
ChemMedChem; 2012 Jul; 7(7):1267-75. PubMed ID: 22615183
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of tailor-made glycoconjugate mimetics of heparan sulfate that bind IFN-gamma in the nanomolar range.
Lubineau A; Lortat-Jacob H; Gavard O; Sarrazin S; Bonnaffé D
Chemistry; 2004 Sep; 10(17):4265-82. PubMed ID: 15352109
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factors share binding sites in heparan sulphate.
Kreuger J; Jemth P; Sanders-Lindberg E; Eliahu L; Ron D; Basilico C; Salmivirta M; Lindahl U
Biochem J; 2005 Jul; 389(Pt 1):145-50. PubMed ID: 15769253
[TBL] [Abstract][Full Text] [Related]
7. Probing the interactions of phosphosulfomannans with angiogenic growth factors by surface plasmon resonance.
Cochran S; Li C; Fairweather JK; Kett WC; Coombe DR; Ferro V
J Med Chem; 2003 Oct; 46(21):4601-8. PubMed ID: 14521421
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
Ashikari-Hada S; Habuchi H; Sugaya N; Kobayashi T; Kimata K
Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of fibroblast growth factor activity by synthetic heparin oligosaccharide glycodendrimers.
de Paz JL; Noti C; Böhm F; Werner S; Seeberger PH
Chem Biol; 2007 Aug; 14(8):879-87. PubMed ID: 17719487
[TBL] [Abstract][Full Text] [Related]
10. Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb.
Luo Y; Ye S; Kan M; McKeehan WL
J Cell Biochem; 2006 Apr; 97(6):1241-58. PubMed ID: 16315317
[TBL] [Abstract][Full Text] [Related]
11. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate mimicry: a synthetic glycoconjugate that recognizes the heparin binding domain of interferon-gamma inhibits the cytokine activity.
Sarrazin S; Bonnaffé D; Lubineau A; Lortat-Jacob H
J Biol Chem; 2005 Nov; 280(45):37558-64. PubMed ID: 16155294
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides.
Liu L; Bytheway I; Karoli T; Fairweather JK; Cochran S; Li C; Ferro V
Bioorg Med Chem Lett; 2008 Jan; 18(1):344-9. PubMed ID: 17981035
[TBL] [Abstract][Full Text] [Related]
14. Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans.
Chu CL; Goerges AL; Nugent MA
Biochemistry; 2005 Sep; 44(36):12203-13. PubMed ID: 16142919
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88).
Karoli T; Liu L; Fairweather JK; Hammond E; Li CP; Cochran S; Bergefall K; Trybala E; Addison RS; Ferro V
J Med Chem; 2005 Dec; 48(26):8229-36. PubMed ID: 16366604
[TBL] [Abstract][Full Text] [Related]
16. Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies.
Lensen JF; Rops AL; Wijnhoven TJ; Hafmans T; Feitz WF; Oosterwijk E; Banas B; Bindels RJ; van den Heuvel LP; van der Vlag J; Berden JH; van Kuppevelt TH
J Am Soc Nephrol; 2005 May; 16(5):1279-88. PubMed ID: 15788473
[TBL] [Abstract][Full Text] [Related]
17. Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions.
Noti C; de Paz JL; Polito L; Seeberger PH
Chemistry; 2006 Nov; 12(34):8664-86. PubMed ID: 17066397
[TBL] [Abstract][Full Text] [Related]
18. PI-88 and novel heparan sulfate mimetics inhibit angiogenesis.
Ferro V; Dredge K; Liu L; Hammond E; Bytheway I; Li C; Johnstone K; Karoli T; Davis K; Copeman E; Gautam A
Semin Thromb Hemost; 2007 Jul; 33(5):557-68. PubMed ID: 17629854
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of a glucuronic acid and glucose conjugate library and evaluation of effects on endothelial cell growth.
Pitt N; Duane RM; O'Brien A; Bradley H; Wilson SJ; O'Boyle KM; Murphy PV
Carbohydr Res; 2004 Aug; 339(11):1873-87. PubMed ID: 15261580
[TBL] [Abstract][Full Text] [Related]
20. Rerouting of fibroblast growth factor 2 to the classical secretory pathway results in post-translational modifications that block binding to heparan sulfate proteoglycans.
Wegehingel S; Zehe C; Nickel W
FEBS Lett; 2008 Jul; 582(16):2387-92. PubMed ID: 18538671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
